Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

14.75 

0.03 0.2%

as of Mar 28 '17 16:00

52 Week Range:

13.72 22.58


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

iKang Healthcare Group, Inc., together with its subsidiaries, provides preventive healthcare solutions in the People’s Republic of China. The company operates in two segments, Medical Examinations and Other Medical Services, and Dental Services. It offers a range of medical examinations, including internal, gynecology, ophthalmology, ENT, dental, lab tests, electrocardiogram, ultrasound, and X-ray examination items. The company also provides value-added services at selected medical centers, such as disease screening focusing on cancer screening, cardiovascular and chronic disease screening, and functional medicine testing; dental care comprising oral health, pediatric and cosmetic dentistry, orthodontics, and dental implants; outpatient services, which consists of acupuncture, Chinese medicine, gynecology, internal medicine, obstetrics, ophthalmology, pediatrics, urology, and minor surgery; and on-site healthcare management or clinical services. It primarily serves corporate and individual customers through a network of self-owned medical centers and the facilities of third-party service providers. As of June 9, 2016, it owned and operated a network of 89 self-owned medical centers in 27 cities of China, including Beijing, Shanghai, Guangzhou, Shenzhen, Chongqing, Tianjin, Nanjing, Suzhou, Hangzhou, Chengdu, Fuzhou, Changchun, Jiangyin, Changzhou, Wuhan, Changsha, Yantai, Yinchuan, Weihai, Weifang, Shenyang, Xi’an, Wuhu, Guiyang, Ningbo, and Foshan, as well as Hong Kong. The company was formerly known as China iKang Healthcare, Inc. and changed its name to iKang Healthcare Group, Inc. in February 2014. iKang Healthcare Group, Inc. is headquartered in Beijing, the People’s Republic of China.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16
Equity (BVPS) 4.77
5.30
growth rate 11.1%
Earnings BIT 6.07
14.33
18.58
32.18
growth rate 136.1% 29.7% 73.2%
Avg.PE -54.85
42.33
71.04
growth rate 100.0% 67.8%
ROA 5.29
-59.37
-2.95
7.16
2.81
growth rate -100.0% 0.0% 100.0% -60.8%
ROE 27.90
5.54
growth rate -80.1%
ROIC 20.81
4.24
growth rate -79.6%
Cur. Ratio 0.89
1.41
1.07
1.71
1.54
growth rate 58.4% -24.1% 59.8% -9.9%
Quick Ratio 0.72
1.27
0.67
1.05
0.99
growth rate 76.4% -47.2% 56.7% -5.7%
Leverage 1.56
2.34
growth rate 50.0%
Balance Sheet Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16
Acct.Receivable 18.40
33.55
42.90
65.60
86.88
growth rate 82.3% 27.9% 52.9% 32.4%
Acct.Payable 41.80
55.67
67.86
83.76
growth rate 33.2% 21.9% 23.4%
Cur.Assets 37.30
104.48
110.83
278.67
305.70
growth rate 180.1% 6.1% 151.4% 9.7%
Total Assets 87.30
165.36
250.23
499.00
803.64
growth rate 89.4% 51.3% 99.4% 61.1%
Cash 11.90
63.15
46.23
151.75
139.95
growth rate 430.7% -26.8% 228.3% -7.8%
Inventory 1.00
1.16
1.69
2.66
4.02
growth rate 16.2% 45.7% 57.2% 50.9%
Cur.Liabilities 42.10
73.92
103.44
163.15
199.00
growth rate 75.6% 39.9% 57.7% 22.0%
Liabilities 139.50
75.58
112.67
179.87
460.82
growth rate -45.8% 49.1% 59.7% 156.2%
LT Debt 0.00
0.00
1.87
229.47
growth rate 1,009.2%
Equity 319.13
342.83
growth rate 7.4%
Common Shares 14.00
13.00
64.00
68.00
68.00
growth rate -7.1% 392.3% 6.3% 0.0%
Cash Flow Statement Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16
Capital Expenditures 4.90
12.20
10.00
35.84
39.77
37.02
growth rate 149.0% -18.0% 258.4% 11.0% -6.9%
Cash Dividends 0.30
0.40
0.00
0.04
0.19
0.80
growth rate 33.3% -100.0% 338.6% 311.9%
Cash From OA 10.80
14.00
16.00
34.30
41.10
43.60
growth rate 29.6% 14.3% 114.4% 19.8% 6.1%
FCF per Share -0.02
0.01
growth rate 100.0%
Sale Purchase of Stock 45.00
19.58
138.45
8.60
growth rate -56.5% 607.1% -93.8%
FCF 6.00
2.00
6.00
-2.00
1.00
6.00
growth rate -66.7% 200.0% -100.0% 100.0% 500.0%
Income Statement Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16
Sales 68.20
93.70
134.00
202.30
290.78
370.81
growth rate 37.4% 43.0% 51.0% 43.7% 27.5%
Op.Income 6.00
14.40
12.00
21.61
27.11
18.33
growth rate 140.0% -16.7% 80.1% 25.5% -32.4%
IBT 6.10
14.30
18.58
32.18
40.16
24.06
growth rate 134.4% 30.0% 73.2% 24.8% -40.1%
Net Income 3.60
9.70
12.00
21.61
27.11
18.33
growth rate 169.4% 23.7% 80.1% 25.5% -32.4%
EPS 0.00
0.10
-5.61
-0.48
0.40
0.27
growth rate -100.0% 0.0% 100.0% -32.5%
Gross Profit 28.40
44.20
63.00
95.90
135.84
159.90
growth rate 55.6% 42.5% 52.2% 41.7% 17.7%
R&D 0.70
0.70
1.27
1.60
1.40
3.72
growth rate 0.0% 81.4% 26.2% -12.6% 165.2%

Quarterly Statements

Item Name Jun '14 Dec '15 Mar '16 Jun '16 Sep '16
Balance Sheet
Acct.Receivable 51.70
95.00
84.00
103.00
125.00
growth rate 83.8% -11.6% 22.6% 21.4%
Acct.Payable 35.00
28.00
30.00
39.00
growth rate -20.0% 7.1% 30.0%
Cur.Assets 279.80
451.00
306.00
271.00
276.00
growth rate 61.2% -32.2% -11.4% 1.9%
Total Assets 428.80
801.00
804.00
768.00
780.00
growth rate 86.8% 0.4% -4.5% 1.6%
Cash 151.50
129.00
108.00
62.00
72.00
growth rate -14.9% -16.3% -42.6% 16.1%
Inventory 1.80
4.00
4.00
4.00
5.00
growth rate 122.2% 0.0% 0.0% 25.0%
Cur.Liabilities 128.70
221.00
199.00
180.00
212.00
growth rate 71.7% -10.0% -9.6% 17.8%
Liabilities 136.10
418.00
438.00
415.00
418.00
growth rate 207.1% 4.8% -5.3% 0.7%
LT Debt 0.00
187.00
229.00
226.00
198.00
growth rate 22.5% -1.3% -12.4%
Equity 292.70
growth rate
Common Shares 32.74
growth rate
Cash Flow Statement Jun '14 Dec '15 Mar '16 Jun '16 Sep '16
Capital Expenditures
growth rate
FCF
growth rate
Income Statement Jun '14 Dec '15 Mar '16 Jun '16 Sep '16
Sales 60.20
133.00
53.00
101.00
120.00
growth rate 120.9% -60.2% 90.6% 18.8%
Op.Income 5.70
20.00
-26.00
2.00
6.00
growth rate 250.9% -100.0% 100.0% 200.0%
IBT 5.30
growth rate
Net Income 1.90
20.00
-26.00
2.00
6.00
growth rate 952.6% -100.0% 100.0% 200.0%
EPS 0.03
growth rate
Gross Profit 29.10
68.00
5.00
45.00
54.00
growth rate 133.7% -92.7% 800.0% 20.0%
R&D 0.20
growth rate

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (70.35)

YOY Growth Grade:

C (53.74)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

Current EPS is negative, therefore value price cannot be calculated.

PE and EPS

Historical Current Forward
PE 247.50 -491.67 25.71
EPS / Growth 0.0% -0.03 45.0%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 7.4%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 0.0% 3.7% 3.7%
Future PE 0.00 16.58 16.58
Future EPS 0.00 0.00 0.00
Value Price
MOS %
0.00
-100.0%
0.00
-100.0%
0.00
-100.0%
MOS Price 0.00 0.00 0.00
IRT 99.00 99.00 99.00

Graham Number:

Current EPS is negative, therefore Graham Number cannot be calculated.
NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

Access denied

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE.